Saint Louis University and Industry Partners Discover Treatment for Rare, Genetic Liver Disease

Newswise – ST. LOUIS, July 8, 2022 — Researchers from Saint Louis University’s School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug for treating a rare, genetic liver disease that previously could only be treated with a liver transplant. The study, “Fazirsiran for liver disease associated with alpha1-antitrypsin …

Saint Louis University and Industry Partners Discover Treatment for Rare, Genetic Liver Disease Read More »